Trade Mark Journal No.2026/024 12 June 2026
UK00004396671 3 June 2026 (44)

International priority date claimed: 9 February 2026
(United States of America)
(99642876)
- Class 44
- Providing information in the field of Alzheimer’s disease; Providing a website featuring information on managing behavioural symptoms associated with Alzheimer’s disease.
Axsome Therapeutics, Inc.
Representative: Keltie LLP